Which Patients with Coronary Artery Disease are Most Prone to Develop a Coronary Artery Event (Presumably Thrombosis)?

• References

• 1 Bottiger L.E., and Carlson L.A.. 1973. The Stockholm prospective study 2. New events of coronary heart disease at initial examination, 9 year follow-up. Early Phases of Coronary Heart Disease. ed. Waldenstrom J., Larsson T., and Ljungstedt N.. publ. Nordiska Bokhandelns; Stockholm.:
• 2 Carvalho A.C.A., Colman R.W., and Lees R.S.. 1974; Platelet function in hyperlipoproteinaemia New England. Journal of Medicine 290: 434.
• 3 Collen D., and de Cock F.. 1975; A tanned red cell haemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin - antiplasmin complexes in human plasma. Thrombosis Research 7: 235.
• 4 Collen D., de Cock F., and Verstraete M.. 1975; Immunochemical distinction between antiplasmin and α_r antitrypsin. Thrombosis Research 7: 245.
• 5 Egeberg O.. 1965; Inherited anti-thrombin deficiency causing thrombophilia. Thrombosis Diathesis Haemorrhagica 13: 516.
• 6 Fletcher A. P., Alkjaersig M., O’Brien J.R., Tulevski V.G.. 1970; Blood hypercoagulability and thrombosis. Transactions of the Association of American Physicians 83: 159.
• 7 Fletcher A. P., Alkjaersig N.. 1977; The use and monitoring of antithrombotic drug therapy. The need for a new approach. Thrombosis and Haemostasis 38: 881.
• 8 Gaarder A., Jonsen J., Lalano S., Hellem A., and Owren P.A.. 1961; Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192: 531.
• 9 Haerem J.W.. 1972; Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 15: 199.
• 10 Harker L. A., and Slichter S.J.. 1970; Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New England Journal of Medicine 287: 1302.
• 11 Harker L. A., and Slighter S.J.. 1974; Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thrombosis Diathesis Haemorrhagica 31: 188.
• 12 Heene D.L., and Matthias F.R.. 1973; Adsorption of fibrinogen derivatives on insolubilized fibrinogen and fibrinmonomer. Thrombosis Research 2: 137.
• 13 Howie P.W., Mallinson A.C., Prentice C.R.M., Horne C.H.W., and McNicol G.P.. 1970; Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet 2: 1329.
• 14 Kaulla E. von, and Kaulla K.N. von. 1970; Oral contraceptives and low antithrombin III deficiency. Lancet 1: 36 (letter)
• 15 Largo R., Heller V., and Straub P. W.. 1976; Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers. Blood 47: 991.
• 16 Lowe G.D.O., Reavey M.M., Johnston R.V., Forbes C.D., Prentice C.R.M.. Increased platelet aggregates in vascular and nonvascular illness: correlation with plasma fibrinogen and effect of ancrod. Thrombosis Research (in press)
• 17 Ludlam C.A., Moore S., Bolton A.E., Pepper D.S., and Cash J.D.. 1975; The release of a human platelet specific protein measured by a radioimmunoassay. Thrombosis Research 6: 543.
• 18 Marciniak E., Farley C.H., and DeSimone P.A.. 1974; Familial thrombosis due to antithrombin III deficiency. Blood 43: 219.
• 19 Maseri A., L’Abbate A., Pesola A., Ballqestra A.M., Marzilli M., Maltinti G., Severi S., De Nes D.M., Parodi O., and Biagini A.. 1977; Coronary vasospasm in angina pectoris. Lancet 1: 713.
• 20 Matthias F.R., Reinicke R., and Heene D.L.. 1977; Affinity chromatography and quantitation of soluble fibrin from plasma. Thrombosis Research 10: 365.
• 21 Meade T.W., and North W.R.S.. 1977; Population-based distributions of haemostatic variables. British Medical Bulletin 33: 283.
• 22 Merskey C., Gordon H., and Lackner H.. 1960; Blood coagulation and fibrinolysis in relation to coronary heart disease. British Medical Journal 1: 219.
• 23 Mitchell J.R.A., and Schwartz C.V.. 1965. Arterial Disease. Blackwell Scientific Publications; Oxford.:
• 24 Moore S., Pepper D.S., and Cash J.D.. 1975; a The isolation and characterization of a platelet specific globulin (thromboglobulin) and the detection of anti-urokinase and anti-plasmin released from thrombin aggregated washed human platelets. Biochimica et biophysoca acta 379: 360.
• 25 Moore S., Pepper D. S., and Cash J. D.. 1975; b The isolation and characterization of platelet factor 4 released from thrombin aggregated washed human platelets and its dissociation into subunits and the isolation of membrance bound antiheparin activity. Biochimica et biophysica acta 379: 370.
• 26 Moroi M.O., Aoki N.. 1976; Isolation and characterization of α₂-plasmin inhibitor from human plasma. Journal of Biological Chemistry 251: 2956.
• 27 Nilsson I.M.. 1974. Haemorrhagic and thrombotic diseases. Publisher: Wiley; London and New York: pp. 133.
• 28 Nossel H.L.. 1976; Radioimmunoassay of fibrinopeptides in relation to intrevascular coagulation and thrombosis. New England Journal of Medicine 295: 428.
• 29 O’Brien J.R., Etherington M., Jamieson S., Klaber M.R., and Lincoln S.V.. 1974; Platelet function long after arterial and venous thrombosis. Thrombosis Diathesis Haemorrhagica 31: 279.
• 30 O’Brien J.R., Etherington M., Jamieson S., Lawford P., Lincoln S.V., and Alkjaersig N. V.. 1975; Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thrombosis Diathesis Haemorrhagica 34: 483.
• 31 Raper C.G.L.. 1978; Circulating platelet aggregates. Thrombosis Haemostasis 39: 537.
• 32 Reinicke R., Matthias F.R., and Lasch H.G.. 1977; Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy. Thrombosis Research 11: 365.
• 33 Roberts W.C., and Buja L.M.. 1972; The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. A study of 107 necropsy patients. American Journal of Medicine 52: 425.
• 34 Rosing D.R., Brakman P., Redwood D.R., Goldstein R.E., Beiser G.D., Astrup T., and Epstein S.E.. 1970; Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circulation Research 27: 171.
• 35 Rosing D.R., Redwood D.R., Brakman P., Astrup T., and Epstein S.E.. 1973; Impairment of the diurnal fibrinolytic response in man. Effects of ageing, type IV hyperlipidaemia and coronary artery disease. Circulation Research 32: 752.
• 36 Smythe H.A., Ogryzlo M.A., Murphy E.A., and Mustard J.F.. 1965; The effect of sulfinpyrazone (Anturan) on platelet economy and blood coagulation in man. Canadian Medical Association Journal 92: 818.
• 37 Steele P.P., Battock D., and Genton E.. 1975; Effects of Clofibrate and sulphinpyrazone on platelet survival time in coronary artery disease. Circulation 52: 473.
• 38 Steele P.P., Battock D., Pappas G., and Genton E.. 1976; Correlation of platelet survival time with occlusion of saphenous vein aortocoronary bypass grafts. Circulation 53: 685.
• 39 Stormorken H., and Erikssen J.. 1977; Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle-aged man. Thrombosis & Haemostasis 38: 874.
• 40 ten Cate J. W., Vos J., Oosterhuis A., Prenger D., and Jenkins C.S.P.. 1978; Spontaneous platlet aggregation in cerebrovascular disease. Thrombosis and Haemostasis 39: 223.
• 41 Vreeken J., and van Aken W.G.. 1971; Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 2: 1394.
• 42 Walsh P.N.. 1972; The role of platelets in the contact phase of blood coagulation. British Journal of Haematology 22: 237.
• 43 Walsh P.N., Pareti F.I., and Corbett J.J.. 1976; Platelet coagulant activities and serum lipids in transient cerebral ischaemia. New England Journal of Medicine 295: 854.
• 44 Weily H., Steele P.P., Davies H., Pappas G., and Genton E.. 1974; Platelet survival in patients with substitute heart valves. New England Journal of Medicine 290: 534.
• 45 Wu K.K., and Hoak J.C.. 1976; Spontaneous platelet aggregation in arterial insufficiency: mechanisms and applications. Thrombosis and Haemostasis 35: 702.